A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models.
Chronic nerve pain can persist long after an injury and often responds poorly to standard pain medications. Researchers at The University of Texas MD Anderson Cancer Center now report evidence that BRAF, a protein best known for its role in cancer, may also help initiate, intensify, and sustain pain signaling after nerve damage.
In preclinical models, drugs that inhibit BRAF signaling reduced pain sensitivity, pointing to a possible new use for treatments already developed for cancer.
The research was published in Science Signaling. It was co-led by Shao-Rui Chen, M.D., professor of Anesthesiology and Perioperative Medicine, and Hui-Lin Pan, M.D., Ph.D., endowed chair of Anesthesiology and Perioperative Medicine.
“Our findings identify the cancer-promoting protein BRAF as a key driver of pathological pain signaling following nerve injury,” Pan said. “Because BRAF inhibitors are already approved for cancer treatment, this discovery raises the possibility of rapidly repurposing existing therapies to reduce the level of pain signals entering the spinal cord and improve patient quality of life.”

Neuropathic pain, or chronic pain caused by damaged nerves, can result from injury, disease, or even life-saving cancer treatments. It can be severe and long lasting, and conventional pain medicines often provide limited relief.
The researchers focused on NMDA receptors, protein channels in the brain and spinal cord that help nerve cells communicate. Following nerve damage, these receptors can become overly active and strengthen pain signals. The researchers investigated whether BRAF helps drive that change.
In preclinical nerve injury models, BRAF traveled from peripheral sensory nerve cells to their endings in the spinal cord. Once there, it activated molecular signaling that increased NMDA receptor activity. The researchers also observed a correlation between proteins involved in BRAF signaling and NMDA receptors in samples of human spinal cord tissue.
Together, those observations suggested that blocking BRAF might reduce excessive NMDA receptor activity and, in turn, lessen pain signaling.

Existing cancer drugs reduced pain sensitivity
The researchers then tested drugs that interfere with this pathway. In preclinical models, the BRAF inhibitor vemurafenib and the MEK inhibitor selumetinib reduced sensitivity to touch, pressure, and heat. Neither drug altered normal responses in models without nerve injury.

Genetic experiments provided additional evidence for BRAF’s role. Removing the Braf gene produced less persistent pain sensitivity, while directly activating BRAF triggered pain sensitivity even in models without nerve damage. These opposing results further supported the idea that BRAF contributes to both the development and persistence of neuropathic pain.
The findings remain preclinical. Before BRAF inhibitors could move into human trials for neuropathic pain, researchers will need to determine appropriate doses, delivery methods, and potential side effects. They also want to learn what causes BRAF to move from peripheral nerves to the spinal cord after an injury.
Even with those questions unresolved, the results link BRAF signaling with NMDA receptor activation in the spinal cord and suggest that currently available BRAF inhibitors could have therapeutic potential for neuropathic pain.
Reference: “BRAF recruitment to spinal sensory synapses promotes neuropathic pain by potentiating transsynaptic NMDA receptor activity” by Daozhong Jin, Hong Chen, Yuying Huang, Shao-Rui Chen and Hui-Lin Pan, 25 August 2026, Science Signaling.
DOI: 10.1126/scisignal.aeh6852
This study was funded by the National Institutes of Health and the Pamela and Wayne Garrison Distinguished Chair Endowment.
News – Curated by Amanda Scott, Alias Group Creative
Follow her on Bluesky
Human Bodies Are Producing Two Billion Tons of CO2 a Year
A new study reveals that the amount of carbon dioxide produced by human metabolism has increased dramatically over three decades. The carbon dioxide produced by human bodies as they convert food into energy increased [...]
A Hidden DNA Mechanism Could Explain How 20% of Human Cancers Develop
Researchers have identified an unexpected molecular vulnerability in cancers carrying BAF mutations. Mutations found in roughly 20% of human cancers may promote tumor growth by changing how DNA is organized inside cells. Researchers have [...]
Ebola kills over 5,300 in fastest-growing outbreak on record
Africa’s latest Ebola outbreak has killed nearly 5,400 people, the vast majority of them in the Democratic Republic of Congo (DRC), according to the continent’s top health agency. Africa Centres for Disease Control and [...]
China makes early progress in using sound waves to stimulate damaged brains
Chinese researchers are testing whether focused ultrasound can help restore consciousness in patients with severe brain injuries, adding to a growing international effort to use sound waves to stimulate deep brain structures without surgery. [...]
Micro-drones fly through the body thanks to ultrasound
At the EPFL, micro-drones have been developed that can be moved without a motor or battery.No motors, no batteries, no electronics on board, just small cavities that convert sound waves into thrust: this is [...]
A Single Enzyme Could Hold the Key to Treating a Devastating Brain Disorder
Blocking an enzyme’s production restored brain growth and healthy behaviors in mice engineered to develop Angelman syndrome, pointing to a possible treatment target. Children with Angelman syndrome begin to show difficulties with thinking and [...]
Scientists Develop a Clever New Way To Kill Cancer Cells From the Inside
Scientists have developed an experimental strategy that exploits a chemical byproduct of cancer cells to produce anticancer drugs directly inside them. Scientists in Japan have developed an experimental method that uses a chemical produced [...]
Our books are available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
After only a short training, people in a coma managed to send targeted signals
Researchers have succeeded in communicating with brain-injured patients who are unconscious. They see enormous potential in this for future treatments. Patients who lie motionless in bed after a severe brain injury and do not [...]
MIT Scientists Reprogram Immune Cells Inside the Body To Destroy Cancer
Natural killer cells reprogrammed inside mice eliminated lymphoma tumors and helped damaged livers heal, though whether this approach could help people with cancer or autoimmune disease remains unknown. To make a cancer treatment from [...]
Melanoma mRNA Vaccine Shows Promise in Preventing Disease Recurrence
Key takeaways: Phase 3 trial finds personalized intismeran plus pembrolizumab may better prevent high-risk melanoma recurrence after surgery The trial enrolled 1,137 patients and builds on phase 2 results showing about half the recurrence [...]
Scientists Discover a Powerful New Weapon Against a Dangerous Gut Infection
The promise of an experimental treatment for C. difficile gut infections lies partly in the bacteria it leaves alive, according to early laboratory and mouse research. Broad-spectrum antibiotics can disrupt the gut’s microbial community, [...]
Your Bones May Hold a Hidden Clue to Blood Cancer Survival
For people with blood cancers called myelodysplastic syndromes, osteoporosis may hold an overlooked clue to survival, a three-year observational study suggests. In blood cancers that develop in the bone marrow, an important clue to [...]
Researchers Discover What Reading for Pleasure May Be Doing to Your Brain
Reading for pleasure may offer surprising benefits for the brain, with research linking the habit to better mental health, stronger cognitive abilities, and a lower risk of dementia. Reading for pleasure may do far [...]
Scientists Discover a Hidden Trigger That Keeps Inflammation Alive
Inflammation persists after proteins detach from immune receptors, revealing a potential target for autoimmune treatments. Since a Nobel Prize-winning discovery in the 1990s identified molecules called Toll-like Receptors as the guardians of the human [...]
A Virus Gives Itself Away the Moment It Attacks
Researchers have found the trigger behind a powerful bacterial defense against viruses. Viruses that prey on bacteria could become an increasingly important tool for treating bacterial infections, particularly as antibiotic resistance makes some infections [...]















